Announcement 226 - Clarification of expectations for FY2021-22
Share price & Turnover
Calendar
| 2025-10-09 | Annual General meeting |
| 2025-09-11 | Year-end Report 2025 |
| 2025-02-05 | Quarterly Report 2025-Q2 |
| 2024-10-11 | Ex-date Ordinary Dividend CHEMM 0.00 DKK |
| 2024-10-10 | Annual General meeting |
| 2024-09-11 | Year-end Report 2024 |
| 2024-02-05 | Quarterly Report 2024-Q2 |
| 2023-10-13 | Ex-date Ordinary Dividend CHEMM 6.00 DKK |
| 2023-10-12 | Annual General meeting |
| 2023-09-14 | Year-end Report 2023 |
| 2023-05-09 | 15-10 2023-Q3 |
| 2023-02-09 | Quarterly Report 2023-Q2 |
| 2022-10-14 | Ex-date Ordinary Dividend CHEMM 0.00 DKK |
| 2022-10-13 | Annual General meeting |
| 2022-09-15 | Year-end Report 2022 |
| 2022-02-08 | Quarterly Report 2022-Q2 |
| 2021-10-15 | Ex-date Ordinary Dividend CHEMM 4.00 DKK |
| 2021-10-14 | Annual General meeting |
| 2021-09-16 | Year-end Report 2021 |
| 2021-02-05 | Quarterly Report 2021-Q2 |
| 2020-10-09 | Ex-date Ordinary Dividend CHEMM 1.50 DKK |
| 2020-10-08 | Annual General meeting |
| 2020-09-17 | Year-end Report 2020 |
| 2020-02-07 | Quarterly Report 2020-Q2 |
| 2020-01-14 | Ex-date Bonus Dividend CHEMM 13 |
| 2020-01-13 | Extra General Meeting 2020 |
| 2019-10-11 | Ex-date Ordinary Dividend CHEMM 7.50 DKK |
| 2019-10-10 | Annual General meeting |
| 2019-09-17 | Year-end Report 2019 |
| 2019-02-08 | Quarterly Report 2019-Q2 |
| 2018-10-12 | Ex-date Ordinary Dividend CHEMM 0.00 DKK |
| 2018-10-11 | Annual General meeting |
| 2018-09-18 | Year-end Report 2018 |
| 2018-02-09 | Quarterly Report 2018-Q2 |
| 2017-11-15 | Annual General meeting |
| 2017-10-13 | Ex-date Ordinary Dividend CHEMM 0.00 DKK |
| 2017-10-12 | Annual General meeting |
| 2017-09-19 | Year-end Report 2017 |
| 2017-02-10 | Quarterly Report 2017-Q2 |
| 2016-10-14 | Ex-date Ordinary Dividend CHEMM 0.00 DKK |
| 2016-10-13 | Annual General meeting |
| 2016-09-20 | Year-end Report 2016 |
| 2016-02-26 | Quarterly Report 2016-Q2 |
| 2015-10-09 | Ex-date Ordinary Dividend CHEMM 0.00 DKK |
| 2015-10-08 | Annual General meeting |
| 2015-05-15 | Quarterly Report 2015-Q3 |
| 2014-10-10 | Ex-date Ordinary Dividend CHEMM 0.00 DKK |
| 2014-10-09 | Annual General meeting |
| 2014-05-15 | Quarterly Report 2014-Q3 |
| 2013-11-15 | Quarterly Report 2014-Q1 |
| 2013-10-11 | Ex-date Ordinary Dividend CHEMM 0.00 DKK |
| 2013-10-10 | Annual General meeting |
| 2013-07-25 | Extra General Meeting 2013 |
| 2013-05-14 | Quarterly Report 2013-Q3 |
| 2012-11-14 | Quarterly Report 2013-Q1 |
| 2012-10-12 | Ex-date Ordinary Dividend CHEMM 0.00 DKK |
| 2012-10-11 | Annual General meeting |
| 2012-05-11 | Quarterly Report 2012-Q3 |
| 2011-11-11 | Quarterly Report 2012-Q1 |
| 2011-10-14 | Ex-date Ordinary Dividend CHEMM 0.00 DKK |
| 2011-10-13 | Annual General meeting |
| 2011-05-13 | Quarterly Report 2011-Q3 |
| 2010-11-12 | Quarterly Report 2011-Q1 |
| 2010-10-06 | Ex-date Ordinary Dividend CHEMM 0.00 DKK |
Description
| Country | Denmark |
|---|---|
| List | Large Cap Copenhagen |
| Sector | Health care |
| Industry | Medical technology |
MEDDELELSE NR. 226
15. august 2022
Præcisering af forventinger til omsætning og driftsresultat for 2021/22
ChemoMetec præciserer hermed forventningerne til omsætningen og driftsresultatet for regnskabsåret 2021/22, som omfatter perioden 1. juli 2021 til 30. juni 2022.
På baggrund af de foreløbige regnskabstal forventer ChemoMetec i 2021/22 en omsætning omkring DKK 427 mio. mod tidligere udmeldt DKK 420-425 mio. Samtidig forventes et driftsresultat (EBITDA) på omkring DKK 223 mio. mod tidligere udmeldt DKK 218-221 mio.
ChemoMetecs årsrapport for 2021/22 forventes offentliggjort torsdag den 15. september 2022.
Yderligere oplysninger
Adm. direktør (CEO) Steen Søndergaard, ChemoMetec A/S
Telefon: (+45) 4813 1020
Om ChemoMetec A/S
ChemoMetec udvikler, producerer og markedsfører instrumenter til celletælling og en lang række andre målinger. ChemoMetecs instrumenter markedsføres globalt inden for blandt andet farma, biotek og landbrug. ChemoMetec har nogle af verdens førende medicinalvirksomheder blandt sine kunder, herunder Novartis, Novo Nordisk, H. Lundbeck, Merck, AstraZeneca og Johnson & Johnson.
ChemoMetec blev etableret i 1997 og er børsnoteret på Nasdaq Copenhagen. Se også www.chemometec.com